News & Updates

Show Multimedia Only

Breath analyser shows promise for sniffing out high-risk MASLD

Exhaled breath analysis using the so-called eNose technology not only accurately identifies individuals with metabolic dysfunction-associated steatotic liver disease (MASLD) but also pinpoints those at high risk of accelerated disease progression.

Breath analyser shows promise for sniffing out high-risk MASLD

a day ago

Icosabutate shows potential as treatment for MASH

24 Aug 2025

Treatment with icosabutate is associated with encouraging fibrosis and noninvasive biomarker data, lending support for its development in patients with metabolic dysfunction-associated steatohepatitis (MASH), reports a study.

Icosabutate shows potential as treatment for MASH

24 Aug 2025

Bile acid accumulation predicts liver injury after portoenterostomy

23 Aug 2025

The accumulation of altered serum bile acids appears to increase the risk of liver disease progression and result in poorer transplant-free survival following Kasai portoenterostomy (KPE) for biliary atresia (BA), a study has shown.

Bile acid accumulation predicts liver injury after portoenterostomy

23 Aug 2025

No mortality benefit with longer antibiotic prophylaxis durations in cirrhosis, upper GI bleeds

15 Aug 2025

In patients with cirrhosis and upper gastrointestinal (GI) bleeds, mortality outcome does not differ between shorter and longer antibiotic prophylaxis durations, according to a systematic review and Bayesian meta-analysis.

No mortality benefit with longer antibiotic prophylaxis durations in cirrhosis, upper GI bleeds

15 Aug 2025

MASLD severity tied to poor cognitive function, HRQoL in patients with obesity

11 Aug 2025

Greater severity in metabolic dysfunction-associated steatotic liver disease (MASLD) may impair cognitive function and health-related quality of life (HRQoL) in patients with overweight or obesity, suggests a study.

MASLD severity tied to poor cognitive function, HRQoL in patients with obesity

11 Aug 2025

HBV vaccination, HIV PEP compliance low among young sexual assault victims

11 Aug 2025 by

Many paediatric sexual assault victims do not receive hepatitis B virus (HBV) postexposure vaccination and have low compliance to HIV postexposure prophylaxis (PEP), reveals a study in Singapore.

HBV vaccination, HIV PEP compliance low among young sexual assault victims

11 Aug 2025

Healthy behaviours may prevent death in cirrhosis patients

05 Aug 2025

Keeping a healthy lifestyle such as having a balanced diet, regular exercise, and quality sleep may provide survival benefits to patients with cirrhosis, suggests a study.

Healthy behaviours may prevent death in cirrhosis patients

05 Aug 2025

Awareness, linkage to care may motivate people with HCV to seek treatment

05 Aug 2025 by

Nearly one in five hepatitis C virus (HCV) infections in the last decade have been treated with direct-acting antivirals (DAAs), as well as about a third of the target population, according to a study.

Awareness, linkage to care may motivate people with HCV to seek treatment

05 Aug 2025

No excess liver cancer risk seen with oral contraceptive use

03 Aug 2025 by

Two large prospective cohorts show no evidence of an association between the use of oral contraceptives and the risk of liver cancer.

No excess liver cancer risk seen with oral contraceptive use

03 Aug 2025

First-line NUC-1031/cisplatin trial for advanced BTC cut short due to futility

24 Jul 2025

A recent phase III trial of NUC-1031/cisplatin has been terminated early due to ineffectiveness as first-line treatment for advanced biliary tract cancer (BTC).

First-line NUC-1031/cisplatin trial for advanced BTC cut short due to futility

24 Jul 2025

News & Updates

Filter by Specialty:

Specialty:

Breath analyser shows promise for sniffing out high-risk MASLD

Breath analyser shows promise for sniffing out high-risk MASLD

Icosabutate shows potential as treatment for MASH

Icosabutate shows potential as treatment for MASH

Bile acid accumulation predicts liver injury after portoenterostomy

Bile acid accumulation predicts liver injury after portoenterostomy

No mortality benefit with longer antibiotic prophylaxis durations in cirrhosis, upper GI bleeds

No mortality benefit with longer antibiotic prophylaxis durations in cirrhosis, upper GI bleeds

MASLD severity tied to poor cognitive function, HRQoL in patients with obesity

MASLD severity tied to poor cognitive function, HRQoL in patients with obesity

HBV vaccination, HIV PEP compliance low among young sexual assault victims

HBV vaccination, HIV PEP compliance low among young sexual assault victims

Healthy behaviours may prevent death in cirrhosis patients

Healthy behaviours may prevent death in cirrhosis patients

Awareness, linkage to care may motivate people with HCV to seek treatment

Awareness, linkage to care may motivate people with HCV to seek treatment

No excess liver cancer risk seen with oral contraceptive use

No excess liver cancer risk seen with oral contraceptive use

First-line NUC-1031/cisplatin trial for advanced BTC cut short due to futility

First-line NUC-1031/cisplatin trial for advanced BTC cut short due to futility